Neuroscience
Rapid Eye Movement Sleep Behavior Disorder
100%
Dimethyl Sulfoxide
50%
Donepezil
50%
Cholinergic
50%
Behavior Disorder
50%
Rapid Eye Movement Sleep
50%
Cuneus
50%
Putamen
43%
Fluorine-18
37%
L-DOPA
37%
Dopaminergic
25%
Frontal Lobe
25%
Positron Emission Tomography
25%
Parietal Cortex
25%
Parkinson's Disease
23%
Dementia with Lewy Bodies
23%
Precuneus
22%
Polysomnography
12%
Thalamus
12%
Cognitive Disorders
11%
Magnetic Resonance Imaging
11%
Voxel-Based Morphometry
5%
Gray Matter Volume
5%
Caudate Nucleus
5%
Cognitive Function
5%
Subcortical Structure
5%
Alpha-Synuclein
5%
Parkinsonism
5%
Keyphrases
Cholinergic Dysfunction
50%
Phenoconversion
50%
Idiopathic Rapid Eye Movement Sleep Behavior Disorder (iRBD)
50%
Cognitively Unimpaired
50%
Cuneus
50%
Donepezil
25%
Fluoro
18%
Putamen
18%
3,4-dihydroxyphenylalanine
18%
Frontal Cortex
12%
Dopaminergic Dysfunction
12%
Parietal Cortex
12%
Positron Emission Tomography
12%
Cortical Atrophy
10%
Synucleinopathy
6%
Parkinsonian
6%
Confidence Interval
6%
Cox Regression
6%
Tomography Image
6%
Biomarker Candidates
6%
Dementia with Lewy Bodies
6%
Linear Regression
6%
Time-to-event Analysis
6%
Polysomnography
6%
In(III)
6%
Parkinson's Disease
6%
Patient Diagnosis
6%
Tracer Uptake
6%
Time Conversion
5%
Caudate nucleus
5%
Medicine and Dentistry
Donepezil
50%
Rapid Eye Movement Sleep Behavior Disorder
50%
Carbon 11
50%
Fluorine-18
37%
Putamen
37%
Levodopa
37%
Parietal Cortex
25%
Frontal Lobe
25%
Positron Emission Tomography
25%
Diffuse Lewy Body Disease
12%
Parkinson's Disease
12%
Synucleinopathies
12%
Biological Marker
12%
Proportional Hazards Model
12%
Linear Regression Analysis
12%
Polysomnography
12%
Thalamus
12%
Radioactive Tracer
12%
